Abstract is: Sabera Nazneen Rahman CBE FMedSci is a geneticist who specialises in cancer research and is a non-executive director for Astra Zeneca. She was previously head of Genetics and Epidemiology at the Institute of Cancer Research.
| human | Q5 |
| P3283 | Bandcamp profile ID | nazneenrahman |
| P1617 | BBC Things ID | 00ce23e4-a192-4b4d-8ffe-abd0ac14ee1e |
| P6178 | Dimensions author ID | 01056542504.81 |
| P646 | Freebase ID | /m/0107_v9q |
| P7502 | Golden ID | Nazneen_Rahman-WJNA48 |
| P856 | official website | http://nazneenrahman.com/ |
| http://www.icr.ac.uk/our-research/researchers-and-teams/professor-nazneen-rahman | ||
| P496 | ORCID iD | 0000-0003-4376-0440 |
| P3829 | Publons author ID | 2658626 |
| P1053 | ResearcherID | D-2802-2013 |
| P1153 | Scopus author ID | 7101749310 |
| P3040 | SoundCloud ID | nazneen-1 |
| P10861 | Springer Nature person ID | 01056542504.81 |
| P2002 | X username | rahman_nazneen |
| P2397 | YouTube channel ID | UCAOwcWp6ByatfvS9UIHVSfg |
| P1416 | affiliation | Institute of Cancer Research | Q6039999 |
| P166 | award received | Commander of the Order of the British Empire | Q12201477 |
| P184 | doctoral advisor | Michael Stratton | Q6834656 |
| P69 | educated at | University of Oxford | Q34433 |
| Redland High School for Girls | Q7306018 | ||
| P108 | employer | AstraZeneca | Q731938 |
| Institute of Cancer Research | Q6039999 | ||
| The Royal Marsden NHS Foundation Trust | Q7761706 | ||
| P734 | family name | Rahman | Q2127407 |
| Rahman | Q2127407 | ||
| Rahman | Q2127407 | ||
| P1412 | languages spoken, written or signed | English | Q1860 |
| P106 | occupation | singer-songwriter | Q488205 |
| geneticist | Q3126128 | ||
| P140 | religion or worldview | Islam | Q432 |
| P21 | sex or gender | female | Q6581072 |
| Q51942868 | 15q overgrowth syndrome: a newly recognized phenotype associated with overgrowth, learning difficulties, characteristic facial appearance, renal anomalies and increased dosage of distal chromosome 15q. |
| Q57920219 | 35th Annual Meeting of the European Association for the Study of Diabetes |
| Q56883844 | 35th Annual Meeting of the European Association for the Study of Diabetes : Brussels, Belgium, 28 September-2 October 1999 |
| Q33606561 | A Cost-Effectiveness Evaluation of Germline BRCA1 and BRCA2 Testing in UK Women with Ovarian Cancer |
| Q35926983 | A WT1 exon 1 mutation in a child diagnosed with Denys-Drash syndrome |
| Q24647081 | A census of human cancer genes |
| Q57250674 | A common coding variant in CASP8 is associated with breast cancer risk |
| Q37124110 | A cost analysis of a cancer genetic service model in the UK |
| Q53160186 | A discrete event simulation to evaluate the cost effectiveness of germline BRCA1 and BRCA2 testing in UK women with ovarian cancer |
| Q24540096 | A gene for lymphedema-distichiasis maps to 16q24.3. |
| Q37272982 | A genome wide linkage search for breast cancer susceptibility genes |
| Q28943448 | A genome-wide association study identifies susceptibility loci for Wilms tumor |
| Q29417036 | A genome-wide association study of early-onset breast cancer identifies PFKM as a novel breast cancer gene and supports a common genetic spectrum for breast cancer at any age. |
| Q33855633 | A genome-wide association study of testicular germ cell tumor |
| Q36435849 | A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11. |
| Q34467375 | A missense mutation in the BRCA2 gene in three siblings with ovarian cancer |
| Q37272989 | A multicenter study of cancer incidence in CHEK2 1100delC mutation carriers |
| Q57272197 | A new familial cancer syndrome including predisposition to Wilms tumor and neuroblastoma |
| Q57272218 | A new gene on the X involved in Fanconi anemia |
| Q35445946 | A new scoring system for the chances of identifying a BRCA1/2 mutation outperforms existing models including BRCAPRO |
| Q42476404 | A novel HER2-positive breast cancer phenotype arising from germline TP53 mutations. |
| Q57305942 | A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer |
| Q34568565 | ATM and breast cancer susceptibility |
| Q34546389 | ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles |
| Q57903143 | Absence of evidence for a familial breast cancer susceptibility gene at chromosome 8p12-p22 |
| Q90413673 | Absence of the TRIP13 c.1060C>T Mutation in Wilms Tumor Patients From Pakistan |
| Q53161373 | Abstract S3-01: The TNT trial: A randomized phase III trial of carboplatin (C) compared with docetaxel (D) for patients with metastatic or recurrent locally advanced triple negative or BRCA1/2 breast cancer (CRUK/07/012) |
| Q38811519 | Accurate clinical detection of exon copy number variants in a targeted NGS panel using DECoN. |
| Q45979098 | Association analysis identifies 65 new breast cancer risk loci. |
| Q24646663 | Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants |
| Q37151879 | Association study of prostate cancer susceptibility variants with risks of invasive ovarian, breast, and colorectal cancer |
| Q35532898 | Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium |
| Q57056093 | Associations of obesity and circulating insulin and glucose with breast cancer risk: a Mendelian randomization analysis |
| Q35832295 | BRCA1 testing should be offered to individuals with triple-negative breast cancer diagnosed below 50 years |
| Q37217525 | Bayesian refinement of association signals for 14 loci in 3 common diseases |
| Q43073371 | Biallelic BRCA2 mutations are associated with multiple malignancies in childhood including familial Wilms tumour |
| Q38758618 | Biallelic TRIP13 mutations predispose to Wilms tumor and chromosome missegregation |
| Q34597168 | Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer |
| Q46115524 | Body mass index and breast cancer survival: a Mendelian randomization analysis |
| Q34327945 | Breast cancer risk and 6q22.33: combined results from Breast Cancer Association Consortium and Consortium of Investigators on Modifiers of BRCA1/2 |
| Q57305977 | Breast-Cancer Risk in Families With Mutations in PALB2 |
| Q34148873 | Breast-cancer risk in families with mutations in PALB2 |
| Q40599031 | CSN and CAVA: variant annotation tools for rapid, robust next-generation sequencing analysis in the clinical setting |
| Q36871605 | Cancer genes associated with phenotypes in monoallelic and biallelic mutation carriers: new lessons from old players |
| Q59565062 | Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT Trial |
| Q57272232 | Case of interstitial 12q deletion in association with Wilms tumor |
| Q58001453 | Case of interstitial 12q deletion in association with Wilms tumor |
| Q28655937 | Characterizing genetic variants for clinical action |
| Q24656264 | Chromosome 6p22 locus associated with clinically aggressive neuroblastoma |
| Q59542947 | Clinical Annotation Reference Templates: a resource for consistent variant annotation |
| Q35560137 | Clinical and genetic heterogeneity in peroneal muscular atrophy associated with vocal cord weakness |
| Q34550837 | Clinical features of NSD1-positive Sotos syndrome |
| Q35794653 | Common germline polymorphisms associated with breast cancer-specific survival |
| Q24645352 | Common variations in BARD1 influence susceptibility to high-risk neuroblastoma |
| Q57272211 | Comparative genomic hybridization and BUB1B mutation analyses in childhood cancers associated with mosaic variegated aneuploidy syndrome |
| Q31082788 | Comparison of 6q25 breast cancer hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC) |
| Q34181322 | Confirmation of 5p12 as a susceptibility locus for progesterone-receptor-positive, lower grade breast cancer |
| Q30338002 | Confirmation of FWT1 as a Wilms' tumour susceptibility gene and phenotypic characteristics of Wilms' tumour attributable to FWT1 |
| Q28189179 | Confirmation of a gene locus for medullary cystic kidney disease (MCKD2) on chromosome 16p12 |
| Q57272213 | Confirmation of a hereditary motor and sensory neuropathy IIC locus at chromosome 12q23-q24 |
| Q43740895 | Constitutional 11p15 abnormalities, including heritable imprinting center mutations, cause nonsyndromic Wilms tumor. |
| Q41920923 | Constitutional aneuploidy and cancer predisposition caused by biallelic mutations in BUB1B. |
| Q35015167 | Constitutional translocation breakpoint mapping by genome-wide paired-end sequencing identifies HACE1 as a putative Wilms tumour susceptibility gene |
| Q57278898 | Correction: Comparison of 6q25 Breast Cancer Hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC) |
| Q60925006 | Correction: Germline mutations in the oncogene EZH2 cause Weaver syndrome and increased human height |
| Q64229627 | Corrigendum: Mutations in the PP2A regulatory subunit B family genes PPP2R5B, PPP2R5C and PPP2R5D cause human overgrowth |
| Q54346685 | Corrigendum: Mutations in the transcriptional repressor REST predispose to Wilms tumor. |
| Q51104305 | Cost-Effectiveness Analysis of Testing for Brca Mutations in Women Diagnosed with Ovarian Cancer and their Female First-Degree Relatives: A Uk Health Service Perspective. |
| Q50963024 | Cost-Effectiveness Analysis of Testing for Brca1 and Brca2 Mutations In Women Diagnosed With Ovarian Cancer and Their Female First- And Second Degree Relatives Using A Discrete Event Simulation: A Uk Health Service Perspective. |
| Q53160166 | CoverView: a sequence quality evaluation tool for next generation sequencing data. |
| Q28388475 | Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations |
| Q34160764 | DICER1 syndrome: clarifying the diagnosis, clinical features and management implications of a pleiotropic tumour predisposition syndrome |
| Q35124732 | Development of cancer genetic services in the UK: A national consultation |
| Q38441111 | Distinct genomic profiles in hereditary breast tumors identified by array-based comparative genomic hybridization |
| Q95383797 | EZH2-Related Overgrowth |
| Q33905913 | Ehlers-Danlos syndrome with severe early-onset periodontal disease (EDS-VIII) is a distinct, heterogeneous disorder with one predisposition gene at chromosome 12p13. |
| Q37475389 | Epigenetic inactivation of the Sotos overgrowth syndrome gene histone methyltransferase NSD1 in human neuroblastoma and glioma |
| Q57250672 | Erratum: Corrigendum: A common coding variant in CASP8 is associated with breast cancer risk |
| Q57053839 | Erratum: Corrigendum: Mutations in the DNA methyltransferase gene DNMT3A cause an overgrowth syndrome with intellectual disability |
| Q57272206 | Estrogen Receptor Status Could Modulate the Genomic Pattern in Familial and Sporadic Breast Cancer |
| Q92268185 | Evaluation of Cancer-Based Criteria for Use in Mainstream BRCA1 and BRCA2 Genetic Testing in Patients With Breast Cancer |
| Q57266770 | Evaluation of Fanconi Anemia genes in familial breast cancer predisposition |
| Q57272214 | Evaluation of NSD2 and NSD3 in overgrowth syndromes |
| Q33894527 | Evaluation of linkage of breast cancer to the putative BRCA3 locus on chromosome 13q21 in 128 multiple case families from the Breast Cancer Linkage Consortium |
| Q57266727 | Evaluation ofRAD50 in familial breast cancer predisposition |
| Q30338283 | Evidence for a familial Wilms' tumour gene (FWT1) on chromosome 17q12–q21 |
| Q36621758 | Evidence for susceptibility genes to familial Wilms tumour in addition to WT1, FWT1 and FWT2 |
| Q33863235 | Exploring the link between MORF4L1 and risk of breast cancer |
| Q41935672 | Facial dysmorphism and digit anomalies in three siblings with severe developmental delay |
| Q37004663 | Familial T-cell non-Hodgkin lymphoma caused by biallelic MSH2 mutations |
| Q43075986 | Familial Wilms tumour resulting from WT1 mutation: intronic polymorphism causing artefactual constitutional homozygosity |
| Q51925069 | Familial gigantism caused by an NSD1 mutation. |
| Q35049319 | Familial vocal fold paralysis |
| Q57272222 | Frequency and Heritability ofWT1Mutations in Nonsyndromic Wilms' Tumor Patients: A UK Children’s Cancer Study Group Study |
| Q34017597 | Gene-gene interactions in breast cancer susceptibility |
| Q36175072 | Gene-panel sequencing and the prediction of breast-cancer risk |
| Q30497558 | Generation of trisomies in cancer cells by multipolar mitosis and incomplete cytokinesis |
| Q37187786 | Genetic predisposition to breast cancer: past, present, and future |
| Q34501408 | Genetic predisposition to neuroblastoma mediated by a LMO1 super-enhancer polymorphism. |
| Q28388497 | Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types |
| Q36842233 | Genome-wide association analysis identifies three new breast cancer susceptibility loci |
| Q35996692 | Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer |
| Q24622610 | Genome-wide association studies identify four ER negative-specific breast cancer risk loci |
| Q37882000 | Genome-wide association studies provide new insights into the genetic basis of testicular germ-cell tumour |
| Q34114293 | Genome-wide association study identifies five new breast cancer susceptibility loci |
| Q24645441 | Genome-wide association study identifies novel breast cancer susceptibility loci |
| Q24550675 | Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls |
| Q24628710 | Genome-wide association study of CNVs in 16,000 cases of eight common diseases and 3,000 shared controls |
| Q92315050 | Genomic variant sharing: a position statement |
| Q34015481 | Genotype-phenotype associations in Sotos syndrome: an analysis of 266 individuals with NSD1 aberrations |
| Q57266552 | Germline RAD51C mutations confer susceptibility to ovarian cancer |
| Q28245028 | Germline mutations in RAD51D confer susceptibility to ovarian cancer |
| Q34086339 | Germline mutations in the PAF1 complex gene CTR9 predispose to Wilms tumour. |
| Q35764341 | Germline mutations in the oncogene EZH2 cause Weaver syndrome and increased human height. |
| Q46959964 | Heterogeneity of familial medulloblastoma and contribution of germline PTCH1 and SUFU mutations to sporadic medulloblastoma |
| Q36115517 | Heterozygosity for mutations in the ataxia telangiectasia gene is not a major cause of radiotherapy complications in breast cancer patients |
| Q24596489 | Human chromosome 7: DNA sequence and biology |
| Q57272175 | ICR142 Benchmarker: evaluating, optimising and benchmarking variant calling using the ICR142 NGS validation series |
| Q35102646 | Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk |
| Q36859142 | Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer |
| Q36086247 | Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus |
| Q64075956 | Identification of new Wilms tumour predisposition genes: an exome sequencing study |
| Q36922317 | Identification of nine new susceptibility loci for testicular cancer, including variants near DAZL and PRDM14 |
| Q36014067 | Identification of novel genetic markers of breast cancer survival |
| Q46103372 | Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer |
| Q37089636 | Implementing rapid, robust, cost-effective, patient-centred, routine genetic testing in ovarian cancer patients |
| Q57742300 | Inherited susceptibility to colorectal adenomas and carcinomas: Evidence for a new predisposition gene on 15q14-q22 |
| Q92282135 | Insights into BRCA Cancer Predisposition from Integrated Germline and Somatic Analyses in 7632 Cancers |
| Q34152903 | Integrative genomics identifies LMO1 as a neuroblastoma oncogene |
| Q29416989 | Large-scale genotyping identifies 41 new loci associated with breast cancer risk |
| Q43076324 | Linkage analysis of 56 multiplex families excludes the Cowden disease gene PTEN as a major contributor to familial breast cancer. |
| Q36621248 | Lobular carcinoma in situ of the breast is not caused by constitutional mutations in the E-cadherin gene |
| Q34020724 | Localization of the gene for distal hereditary motor neuronopathy VII (dHMN-VII) to chromosome 2q14. |
| Q36619290 | Low frequency of germline E-cadherin mutations in familial and nonfamilial gastric cancer |
| Q28215462 | Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations |
| Q35034822 | Mainstreaming genetic testing of cancer predisposition genes |
| Q36043843 | Mammographic breast density and breast cancer: evidence of a shared genetic basis |
| Q36139750 | Mechanisms predisposing to childhood overgrowth and cancer |
| Q55468550 | Medulloblastoma, acute myelocytic leukemia and colonic carcinomas in a child with biallelic MSH6 mutations. |
| Q37046338 | Meta-analysis identifies four new loci associated with testicular germ cell tumor |
| Q57272201 | Methylation-specific multiplex ligation-dependent probe amplification (MS-MLPA) robustly detects and distinguishes 11p15 abnormalities associated with overgrowth and growth retardation |
| Q34497352 | MicroRNA related polymorphisms and breast cancer risk |
| Q41140324 | Molecular causes for BUBR1 dysfunction in the human cancer predisposition syndrome mosaic variegated aneuploidy. |
| Q28388006 | Mosaic PPM1D mutations are associated with predisposition to breast and ovarian cancer |
| Q57272208 | Mosaic variegated aneuploidy without microcephaly: Implications for cytogenetic diagnosis |
| Q35221378 | Multi-stage genome-wide association study identifies new susceptibility locus for testicular germ cell tumour on chromosome 3q25 |
| Q35448081 | Multiple mechanisms are implicated in the generation of 5q35 microdeletions in Sotos syndrome. |
| Q36785681 | Mutation and association analysis of GEN1 in breast cancer susceptibility |
| Q43094703 | Mutation of the RAD51C gene in a Fanconi anemia-like disorder |
| Q36429017 | Mutations in CEP57 cause mosaic variegated aneuploidy syndrome. |
| Q38801974 | Mutations in Epigenetic Regulation Genes Are a Major Cause of Overgrowth with Intellectual Disability |
| Q28236665 | Mutations in RNF135, a gene within the NF1 microdeletion region, cause phenotypic abnormalities including overgrowth |
| Q38683360 | Mutations in the DNA methyltransferase gene DNMT3A cause an overgrowth syndrome with intellectual disability. |
| Q35924047 | Mutations in the PP2A regulatory subunit B family genes PPP2R5B, PPP2R5C and PPP2R5D cause human overgrowth. |
| Q24532773 | Mutations in the gene encoding capillary morphogenesis protein 2 cause juvenile hyaline fibromatosis and infantile systemic hyalinosis |
| Q40341032 | Mutations in the transcriptional repressor REST predispose to Wilms tumor |
| Q47579832 | Mutations of the Uromodulin gene in MCKD type 2 patients cluster in exon 4, which encodes three EGF-like domains |
| Q24615626 | NSD1 mutations are the major cause of Sotos syndrome and occur in some cases of Weaver syndrome but are rare in other overgrowth phenotypes |
| Q37356243 | Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2. |
| Q89882258 | Oncologist-led BRCA 'mainstreaming' in the ovarian cancer clinic: A study of 255 patients and its impact on their management |
| Q40638979 | OpEx - a validated, automated pipeline optimised for clinical exome sequence analysis. |
| Q24615080 | PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene |
| Q53623196 | PHOX2B analysis in non-syndromic neuroblastoma cases shows novel mutations and genotype-phenotype associations. |
| Q43073156 | Partial NSD1 deletions cause 5% of Sotos syndrome and are readily identifiable by multiplex ligation dependent probe amplification |
| Q34378988 | Pathway-based analysis of GWAs data identifies association of sex determination genes with susceptibility to testicular germ cell tumors |
| Q59238509 | Penetrance of Mutations in the Familial Wilms Tumor Gene FWT1 |
| Q48477778 | Periodontal treatment of two siblings with juvenile hyaline fibromatosis. |
| Q36583004 | Prediction of breast cancer risk based on profiling with common genetic variants |
| Q37194147 | Predisposition gene identification in common cancers by exome sequencing: insights from familial breast cancer |
| Q30743260 | Realizing the promise of cancer predisposition genes |
| Q34458554 | Recognition of and Response to neonatal intrapartum-related complications in home-birth settings in Bangladesh. |
| Q57200235 | Refinement of the Gene Locus for Autosomal Dominant Medullary Cystic Kidney Disease Type 1 (MCKD1) and Construction of a Physical and Partial Transcriptional Map of the Region |
| Q64092170 | Resolving the full spectrum of human genome variation using Linked-Reads |
| Q37300024 | Risk of estrogen receptor-positive and -negative breast cancer and single-nucleotide polymorphism 2q35-rs13387042. |
| Q45400063 | Simple detection of germline microsatellite instability for diagnosis of constitutional mismatch repair cancer syndrome |
| Q57272228 | Skeletal muscle involvement in infantile systemic hyalinosis |
| Q34570833 | Sotos syndrome |
| Q35987087 | Stratification of Wilms tumor by genetic and epigenetic analysis |
| Q36542374 | Surveillance for Wilms tumour in at-risk children: pragmatic recommendations for best practice |
| Q36475859 | Syndromes and constitutional chromosomal abnormalities associated with Wilms tumour |
| Q57272243 | THE GENETICS OF BREAST CANCER SUSCEPTIBILITY |
| Q34331070 | Testicular germ cell tumor susceptibility associated with the UCK2 locus on chromosome 1q23. |
| Q35911639 | The ICR1000 UK exome series: a resource of gene variation in an outbred population |
| Q36011878 | The ICR142 NGS validation series: a resource for orthogonal assessment of NGS analysis |
| Q57272178 | The ICR639 CPG NGS validation series: A resource to assess analytical sensitivity of cancer predisposition gene testing |
| Q36409934 | The ICR96 exon CNV validation series: a resource for orthogonal assessment of exon CNV calling in NGS data |
| Q40650143 | The NSD1 and EZH2 overgrowth genes, similarities and differences |
| Q53160175 | The Quality Sequencing Minimum (QSM): providing comprehensive, consistent, transparent next generation sequencing data quality assurance |
| Q53160146 | The Tatton-Brown-Rahman Syndrome: A clinical study of 55 individuals with de novo constitutive DNMT3A variants. |
| Q57272203 | The emerging landscape of breast cancer susceptibility |
| Q57272240 | The familial Wilms' tumour susceptibility gene, FWT1, may not be a tumour suppressor gene |
| Q34390812 | The gene for cherubism maps to chromosome 4p16.3. |
| Q24616457 | The gene for juvenile hyaline fibromatosis maps to chromosome 4q21 |
| Q40681608 | The integration of BRCA testing into oncology clinics |
| Q56625730 | Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles |
| Q43073205 | Update on the Manchester Scoring System for BRCA1 and BRCA2 testing |
| Q33904964 | Variants in CHEK2 other than 1100delC do not make a major contribution to breast cancer susceptibility |
| Q29417028 | Variants near DMRT1, TERT and ATF7IP are associated with testicular germ cell cancer |
| Q53309082 | Weaver syndrome and EZH2 mutations: Clarifying the clinical phenotype. |
| Q42374047 | Wound healing potentials of Thevetia peruviana: Antioxidants and inflammatory markers criteria |
| Q53160608 | Tatton-Brown–Rahman syndrome | named after | P138 |
| Q6834656 | Michael Stratton | doctoral student | P185 |
| Q731938 | AstraZeneca | board member | P3320 |
| bn | নাজনীন রহমান | wikipedia |
| Nazneen Rahman | wikipedia |
Search more.